EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC 4.0

G LP ‐1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea

Cliona O'Donnell, Odhrán Ryan, Andrew E Hogan iD, Desmond Killick, Shane Crilly, Jonathan D Dodd, David J Murphy, Silke Ryan, Donal O'Shea

Obesity · 2024

DOI: 10.1002/oby.24126 ↗

At a glance

Randomisierte kontrollierte Studie in Obesity, 2024. Written by Cliona O'Donnell and 8 co-authors. Institution: Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland. Major MEDLINE topics: Sleep Apnea, Obstructive, Intra-Abdominal Fat, Continuous Positive Airway Pressure, Glucagon-Like Peptide 1. Cited 10 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Health Research Board of Ireland, Health Research Board.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Glucagon‐like peptide‐1 (GLP‐1) analogues are currently the most widely used pharmacotherapies for weight loss. Their primary mechanism of action is attributed to reduction in energy intake. Data from murine studies also support an additional impact of those agents on energy homeostasis through upregulation of visceral adipose tissue (VAT) metabolic activity, but this remains uncertain in humans.

Methods

Here, we present data from a proof‐of‐concept study on 30 individuals with obstructive sleep apnea and obesity who were randomized to a GLP‐1 therapy‐based weight loss regimen, continuous positive airway pressure, or a combination of both for 24 weeks. At baseline and study completion, 18F‐fluorodeoxyglucose (18F‐FDG) positron emission tomography‐computed tomography (PET‐CT) was performed to evaluate VAT metabolic activity, expressed as VAT target to background ratio.

Results

Treatment with GLP‐1, but not with continuous positive airway pressure, was associated with a significant increase in VAT target to background ratio. There was a strong correlation between the increase in VAT metabolic activity and the degree of weight loss.

Conclusions

These data support the hypothesis that upregulation of VAT metabolic activity by GLP‐1 contributes to its weight loss action in humans, and this subject warrants further detailed investigation.

Subjects

MeSH terms (MEDLINE)

Sleep Apnea, ObstructiveIntra-Abdominal FatContinuous Positive Airway PressureGlucagon-Like Peptide 1Weight LossObesityHumansMaleFemaleMiddle AgedPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18AdultProof of Concept Study

Substances

Glucagon-Like Peptide 1Fluorodeoxyglucose F18

Authors and institutions

  • Pulmonary and Sleep Disorders Unit, St. Vincent's University Hospital, Dublin, Ireland.
  • School of Medicine, University College Dublin, Dublin, Ireland.
  • Department of Endocrinology, St. Vincent's University Hospital, Dublin, Ireland.
  • St. Columcille's Hospital, Dublin, Ireland.
  • Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Ireland.
  • Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland.

ORCID profiles: Andrew E Hogan

Funding

  • Health Research Board of Ireland
  • Health Research Board

Cite

APA

O'Donnell, C., Ryan, O., Hogan, A. E., Killick, D., Crilly, S., Dodd, J. D., Murphy, D. J., Ryan, S., & O'Shea, D. (2024). G LP ‐1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea. Obesity. https://doi.org/10.1002/oby.24126

Vancouver

O'Donnell C, Ryan O, Hogan AE, Killick D, Crilly S, Dodd JD, et al. G LP ‐1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea. Obesity. 2024. doi:10.1002/oby.24126

BibTeX
@article{ODonnell2024,
  author = {O'Donnell, Cliona and Ryan, Odhrán and Hogan, Andrew E and Killick, Desmond and Crilly, Shane and Dodd, Jonathan D and Murphy, David J and Ryan, Silke and O'Shea, Donal},
  title = {G LP ‐1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea},
  journal = {Obesity},
  year = {2024},
  doi = {10.1002/oby.24126}
}
Start for free →